(Q40393218)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523031%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

review article

1 reference

title

Envelope sequence variation, neutralizing antibodies, and primate lentivirus persistence (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523031%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Envelope Sequence Variation, Neutralizing Antibodies, and Primate Lentivirus Persistence (English)

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

16 May 2024

1 reference

D. P. Burns

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7523031

16 May 2024

R. C. Desrosiers

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7523031

16 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7523031

16 May 2024

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523031%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

20 October 2019

http://link.springer.com/content/pdf/10.1007/978-3-642-78536-8_11.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Current Topics in Microbiology and Immunology

16 May 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523031%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

188

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523031%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

185-219

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523031%20AND%20SRC:MED&resulttype=core&format=json

Isolation of T-cell tropic HTLV-III-like retrovirus from macaques

20 October 2019

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.3159089

Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120.

1

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.

16 May 2024

2

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients

16 May 2024

3

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120

16 May 2024

4

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Development of vivo of genetic variability of simian immunodeficiency virus

16 May 2024

5

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations

16 May 2024

6

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Identification of a neutralizing domain in the external envelope glycoprotein of simian immunodeficiency virus.

16 May 2024

7

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Human immunodeficiency virus 1. Predominance of a group-specific neutralizing epitope that persists despite genetic variation

16 May 2024

8

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1

16 May 2024

10

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity

16 May 2024

11

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins

16 May 2024

13

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Synergy between human monoclonal antibodies to HIV extends their effective biologic activity against homologous and divergent strains

16 May 2024

14

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Evolution of human influenza A viruses over 50 years: rapid, uniform rate of change in NS gene

16 May 2024

15

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys

16 May 2024

16

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

A caution on the use of SIV/HIV gag antigen detection systems in neutralization assays

16 May 2024

17

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Neutralization-Resistant Antigenic Variants of Caprine Arthritis-Encephalitis Lentivirus Associated with Progressive Arthritis

16 May 2024

21

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization

16 May 2024

22

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Deficient LAV1 neutralising capacity of sera from patients with AIDS or related syndromes

16 May 2024

23

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Genomic changes associated with antigenic variation of visna virus durig persistent infection

16 May 2024

24

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Genomic changes associated with antigenic variation of visna virus. II. Common nucleotide sequence changes detected in variants from independent isolations

16 May 2024

25

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide

16 May 2024

27

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Long-term persistent infection of macaque monkeys with the simian immunodeficiency virus

16 May 2024

29

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

C-terminal fragments of gp120 and synthetic peptides from five HTLV-III strains: prevalence of antibodies to the HTLV-III-MN isolate in infected individuals.

16 May 2024

30

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

High mutation rate of a spleen necrosis virus-based retrovirus vector

16 May 2024

31

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Cell surface changes associated with mutation of visna virus in antibody-treated cell cultures

16 May 2024

33

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

HIV-1 Neutralizing Monoclonal Antibodies Induced by a Synthetic Peptide

16 May 2024

34

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Antigenic variation of caprine arthritis-encephalitis virus during persistent infection of goats

16 May 2024

35

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies

16 May 2024

36

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid

16 May 2024

38

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Strategies for epitope analysis using peptide synthesis.

16 May 2024

39

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus.

16 May 2024

40

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus

16 May 2024

41

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Journal of Acquired Immune Deficiency Syndromes

16 May 2024

42

2

344

M Goodenow

1989

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Immunodominant B-cell epitopes of the HIV-1 envelope recognized by infected and immunized hosts

16 May 2024

43

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees

16 May 2024

44

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Early Immune Responses in Visna, a Slow Viral Disease of Sheep

16 May 2024

45

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.

16 May 2024

46

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies

16 May 2024

47

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons

16 May 2024

48

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Unusual evolutionary conservation and frequent DNA segment exchange in class I genes of the major histocompatibility complex

16 May 2024

50

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Molecular Biology and Evolution

16 May 2024

51

2

289

H Hayashida

1985

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation

16 May 2024

52

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Antibody to lymphadenopathy-associated virus in AIDS.

16 May 2024

53

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization

16 May 2024

55

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody

16 May 2024

56

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody

16 May 2024

57

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals

16 May 2024

59

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination

16 May 2024

60

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Retroviral Recombination and Reverse Transcription

16 May 2024

61

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

16 May 2024

63

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1.

16 May 2024

64

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1

16 May 2024

65

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaques

16 May 2024

66

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans

16 May 2024

67

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III.

16 May 2024

68

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Humoral immune responses to T cell tropic retrovirus simian T lymphotropic virus type III in monkeys with experimentally induced acquired immune deficiency-like syndrome

16 May 2024

69

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Antibodies from human immunodeficiency virus-infected individuals bind to a short amino acid sequence that elicits neutralizing antibodies in animals

16 May 2024

70

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein.

16 May 2024

71

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies

16 May 2024

72

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus

16 May 2024

73

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Antigenic variation of equine infectious anemia virus as detected by virus neutralization. Brief report

16 May 2024

79

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Serological comparison among various strains of equine infectious anemia virus

16 May 2024

80

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

National Institute of Animal Health Quarterly

16 May 2024

81

13

173

Y Kono

1973

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain.

16 May 2024

83

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant

16 May 2024

84

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein

16 May 2024

85

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

16 May 2024

86

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Blocking of human immunodeficiency virus infection depends on cell density and viral stock age

16 May 2024

87

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III.

16 May 2024

89

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Molecular Biology and Evolution

16 May 2024

90

1

94

W-H Li

1983

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Molecular Biology and Evolution

16 May 2024

91

2

150

W-H Li

1985

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Type-Restricted Neutralization of Molecular Clones of Human Immunodeficiency Virus

16 May 2024

92

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII.

16 May 2024

93

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Antigenic Drift in Visna: Virus Variation During Long-term Infection of Icelandic Sheep

16 May 2024

94

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope

16 May 2024

96

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein

16 May 2024

97

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV).

16 May 2024

98

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Antigenic variation of neutralization-sensitive epitopes of caprine arthritis-encephalitis lentivirus during persistent arthritis.

16 May 2024

99

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Characterization of HIV-1 neutralization escape mutants

16 May 2024

100

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type I gp120

16 May 2024

102

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type 1 that induces neutralizing activity

16 May 2024

103

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations

16 May 2024

104

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus

16 May 2024

105

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Complex determinants of macrophage tropism in env of simian immunodeficiency virus

16 May 2024

108

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Evidence for the cooperation of gp120 amino acids 322 and 448 in SIVmac entry

16 May 2024

109

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Antigenic Shift of Visna Virus in Persistently Infected Sheep

16 May 2024

113

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Slow Virus Infection: Replication and Mechanisms of Persistence of Visna Virus in Sheep

16 May 2024

114

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Virus Mutation during 'Slow Infection': Temporal Development and Characterization of Mutants of Visna Virus recovered from Sheep

16 May 2024

115

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus

16 May 2024

116

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Lack of neutralizing antibodies to caprine arthritis-encephalitis lentivirus in persistently infected goats can be overcome by immunization with inactivated Mycobacterium tuberculosis

16 May 2024

117

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain

16 May 2024

118

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats

16 May 2024

120

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

16 May 2024

122

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Characterization of multiple mRNA species of simian immunodeficiency virus from macaques in a CD4+ lymphoid cell line

16 May 2024

123

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions

16 May 2024

124

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations

16 May 2024

125

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Genomic alterations associated with persistent infections by equine infectious anaemia virus, a retrovirus

16 May 2024

126

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Antigenic variation and lentivirus persistence: variations in envelope gene sequences during EIAV infection resemble changes reported for sequential isolates of HIV.

16 May 2024

127

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in Escherichia coli

16 May 2024

129

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Characterization of large deletions occurring during a single round of retrovirus vector replication: novel deletion mechanism involving errors in strand transfer

16 May 2024

134

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope

16 May 2024

135

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene.

16 May 2024

137

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex

16 May 2024

138

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

The accuracy of reverse transcriptase from HIV-1.

16 May 2024

140

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody

16 May 2024

141

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Is there a neutralization epitope in the second conserved domain of HIV-1 envelope protein?

16 May 2024

142

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells

16 May 2024

143

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

16 May 2024

144

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Extensive variation of human immunodeficiency virus type-1 in vivo

16 May 2024

145

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

B- and T-lymphocyte responses to an immunodominant epitope of human immunodeficiency virus

16 May 2024

147

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Antigenic variation in visna virus

16 May 2024

148

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene

16 May 2024

149

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein.

16 May 2024

153

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

16 May 2024

155

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Neutralization of Divergent HIV-1 Isolates by Conformation-Dependent Human Antibodies to Gp120

16 May 2024

156

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody

16 May 2024

158

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Neutralizing monoclonal antibodies to the AIDS virus

16 May 2024

159

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

The Emergence of Antigenic Variants is a Rare Event in Long-term Visna Virus Infection in vivo

16 May 2024

161

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

A human monoclonal antibody against the CD4-binding site of HIV1 gp120 exhibits potent, broadly neutralizing activity

16 May 2024

162

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and the CD4-binding site of gp120

16 May 2024

163

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

An epitope on the surface envelope glycoprotein (gp130) of simian immunodeficiency virus (SIVmac) involved in viral neutralization and T cell activation

16 May 2024

164

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Neutralization of multiple HIV-1 isolates from a single subject by autologous sequential sera

16 May 2024

165

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Identification of simian immunodeficiency virus SIVMAC env gene products

16 May 2024

166

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Isolate-specific neutralizing antibodies in patients with progressive HIV-1-related disease

16 May 2024

167

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Nucleotide sequence of the AIDS virus, LAV

16 May 2024

168

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Fidelity of human immunodeficiency virus type I reverse transcriptase in copying natural DNA.

16 May 2024

169

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides

16 May 2024

170

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients

16 May 2024

171

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Variable and conserved neutralization antigens of human immunodeficiency virus

16 May 2024

172

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes

16 May 2024

173

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus

16 May 2024

174

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution

16 May 2024

175

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Genomic diversity of human T-lymphotropic virus type III (HTLV-III).

16 May 2024

176

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

Rate and mechanism of nonhomologous recombination during a single cycle of retroviral replication.

16 May 2024

177

1 reference

https://api.crossref.org/works/10.1007/978-3-642-78536-8_11

16 May 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523031%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference